At 68 weeks, participants lost an average of 16% of their body weight, slightly exceeding the STEP 1 results
In an interview, Fanelli said he would have never taken the drug if he was aware of the potential risk of vision loss
Use a chair that supports the natural curve of your spine
de Souza, A
More specifically, among these cases, 19 (48.7%) were associated with liraglutide, 9 (23.1%) with dulaglutide, 4 (10.3%) each with exenatide and semaglutide, while 1 (2.6%) case each was linked to lixisenatide, albiglutide, and tirzepatide
"When the GLP-1 drugs are being sold to diabetic patients, that's a completely different story versus when the drug is used for weight management," Han said to UT San Antonio today